The Burman Family To Back $200 Mn Healthcare Fund

The Burman Family - promoters of Dabur India - are backing a $200 Mn PE fund focused on healthcare and life sciences space. The fund is being promoted by former Dabur Pharma CEO – Ajay Kumar Vij and Dabur Group Chairman Anand Burman will be an anchor investor in the fund. The fund is likely to be named as Asia Healthcare Fund.

This would be Burman Family’s second major venture in the Healthcare space. In 2008, they sold their healthcare venture Dabur Pharmaceuticals to Fresenius Kabi, a wholly-owned subsidiary of German health care group Fresenius SE, for $219 Mn. Soon after that Vij exited with a new CEO being appointed by the Fresenius Kabi group.

Burman Family also has contract research firm – Dabur research Foundation which is headed by Ajay Kumar Vij.

Former Dabur India Chairman – V C Burman’s younger son - Gaurav Burman - is the Managing Partner of Elephant Capital, an AIM listed PE firm. He has also worked with Dresdner Kleinwort Capital, a global private equity firm with over US$1.5 Bn under management. His elder brother – Mohit Burman is Managing Director of Elephant Capital.

Recent Transactions In Healthcare Space

London based – Elephant Capital is a sector agnostic fund, which typically invests $10-20 Mn per transaction. Elephant Capital has invested in east India Hotels, Mahina Forgings, Nitco, Obopay and Global Cricket Ventures.

Previous Article

Damodar Valley Corporation To Raise Rs 500 Cr Through NCDs

Next Article

Sheth Creators Raises R80Cr From IIFL PE